GSK (GSK) Revenue & Revenue Breakdown
GSK Revenue Highlights
Latest Revenue (Y)
$30.33B
Latest Revenue (Q)
$7.36B
Main Segment (Y)
Sub Total
Main Geography (Y)
UNITED STATES
GSK Revenue by Period
GSK Revenue by Year
| Date | Revenue | Change |
|---|---|---|
| 2023-12-31 | $30.33B | 3.42% |
| 2022-12-31 | $29.32B | -14.04% |
| 2021-12-31 | $34.11B | 0.04% |
| 2020-12-31 | $34.10B | 1.02% |
| 2019-12-31 | $33.75B | 9.52% |
| 2018-12-31 | $30.82B | 2.10% |
| 2017-12-31 | $30.19B | 8.24% |
| 2016-12-31 | $27.89B | 16.58% |
| 2015-12-31 | $23.92B | 3.99% |
| 2014-12-31 | $23.01B | -13.20% |
| 2013-12-31 | $26.50B | 0.28% |
| 2012-12-31 | $26.43B | -3.49% |
| 2011-12-31 | $27.39B | -3.54% |
| 2010-12-31 | $28.39B | 0.08% |
| 2009-12-31 | $28.37B | 16.49% |
| 2008-12-31 | $24.35B | 7.20% |
| 2007-12-31 | $22.72B | -2.19% |
| 2006-12-31 | $23.23B | 7.23% |
| 2005-12-31 | $21.66B | 8.38% |
| 2004-12-31 | $19.99B | -6.79% |
| 2003-12-31 | $21.44B | 1.08% |
| 2002-12-31 | $21.21B | 3.30% |
| 2001-12-31 | $20.53B | 13.58% |
| 2000-12-31 | $18.08B | 112.94% |
| 1999-12-31 | $8.49B | 6.35% |
| 1998-12-31 | $7.98B | 0.04% |
| 1997-12-31 | $7.98B | -4.33% |
| 1996-12-31 | $8.34B | -20.49% |
| 1995-12-31 | $10.49B | 85.47% |
| 1994-06-30 | $5.66B | 14.73% |
| 1993-06-30 | $4.93B | - |
GSK generated $30.33B in revenue during NA 2023, up 3.42% compared to the previous quarter, and up 98.40% compared to the same period a year ago.
GSK Revenue by Quarter
| Date | Revenue | Change |
|---|---|---|
| 2024-03-31 | $7.36B | -8.56% |
| 2023-12-31 | $8.05B | -1.17% |
| 2023-09-30 | $8.15B | 13.50% |
| 2023-06-30 | $7.18B | 3.27% |
| 2023-03-31 | $6.95B | -5.76% |
| 2022-12-31 | $7.38B | -5.79% |
| 2022-09-30 | $7.83B | 12.99% |
| 2022-06-30 | $6.93B | -29.15% |
| 2022-03-31 | $9.78B | 2.66% |
| 2021-12-31 | $9.53B | 4.96% |
| 2021-09-30 | $9.08B | 12.17% |
| 2021-06-30 | $8.09B | 9.09% |
| 2021-03-31 | $7.42B | -15.12% |
| 2020-12-31 | $8.74B | 1.08% |
| 2020-09-30 | $8.65B | 13.41% |
| 2020-06-30 | $7.62B | -16.13% |
| 2020-03-31 | $9.09B | 2.15% |
| 2019-12-31 | $8.90B | -5.18% |
| 2019-09-30 | $9.38B | 20.18% |
| 2019-06-30 | $7.81B | 1.93% |
| 2019-03-31 | $7.66B | -6.54% |
| 2018-12-31 | $8.20B | 1.30% |
| 2018-09-30 | $8.09B | 10.70% |
| 2018-06-30 | $7.31B | 1.22% |
| 2018-03-31 | $7.22B | -5.46% |
| 2017-12-31 | $7.64B | -2.60% |
| 2017-09-30 | $7.84B | 7.14% |
| 2017-06-30 | $7.32B | -0.87% |
| 2017-03-31 | $7.38B | -2.66% |
| 2016-12-31 | $7.59B | 0.58% |
| 2016-09-30 | $7.54B | 15.46% |
| 2016-06-30 | $6.53B | 4.86% |
| 2016-03-31 | $6.23B | -0.91% |
| 2015-12-31 | $6.29B | 2.60% |
| 2015-09-30 | $6.13B | 4.06% |
| 2015-06-30 | $5.89B | 4.73% |
| 2015-03-31 | $5.62B | -9.12% |
| 2014-12-31 | $6.19B | 9.56% |
| 2014-09-30 | $5.65B | 1.53% |
| 2014-06-30 | $5.56B | -0.93% |
| 2014-03-31 | $5.61B | -18.72% |
| 2013-12-31 | $6.91B | 6.08% |
| 2013-09-30 | $6.51B | -1.63% |
| 2013-06-30 | $6.62B | 2.27% |
| 2013-03-31 | $6.47B | -4.87% |
| 2012-12-31 | $6.80B | 4.21% |
| 2012-09-30 | $6.53B | 1.01% |
| 2012-06-30 | $6.46B | -2.68% |
| 2012-03-31 | $6.64B | -4.84% |
| 2011-12-31 | $6.98B | -1.77% |
| 2011-09-30 | $7.10B | 5.71% |
| 2011-06-30 | $6.72B | 2.05% |
| 2011-03-31 | $6.58B | -8.50% |
| 2010-12-31 | $7.20B | 5.64% |
| 2010-09-30 | $6.81B | -3.02% |
| 2010-06-30 | $7.03B | -4.51% |
| 2010-03-31 | $7.36B | -9.11% |
| 2009-12-31 | $8.09B | 19.77% |
| 2009-09-30 | $6.76B | 0.16% |
| 2009-06-30 | $6.75B | -0.33% |
| 2009-03-31 | $6.77B | -2.04% |
| 2008-12-31 | $6.91B | 17.48% |
| 2008-09-30 | $5.88B | 0.14% |
| 2008-06-30 | $5.87B | 3.31% |
| 2008-03-31 | $5.69B | -5.18% |
| 2007-12-31 | $6.00B | - |
GSK generated $7.36B in revenue during Q1 2024, up -8.56% compared to the previous quarter, and up 99.82% compared to the same period a year ago.
GSK Revenue Breakdown
GSK Revenue Breakdown by Product
Annual Revenue by Product
| Product/Service | Dec 22 | Dec 21 |
|---|---|---|
| Sub Total | $8.96B | - |
| New And Speciality | - | $9.97B |
GSK's latest annual revenue breakdown by segment (product or service), as of Dec 22: Sub Total (100.00%).
GSK Revenue Breakdown by Country
Annual Revenue by Country
| Country | Dec 23 | Dec 22 | Dec 21 | Dec 20 | Dec 19 |
|---|---|---|---|---|---|
| Rest Of World | $13.81B | $14.09B | $18.05B | $18.56B | $18.92B |
| UNITED STATES | $15.82B | $14.54B | $15.09B | $14.56B | $13.89B |
GSK's latest annual revenue breakdown by geography, as of Dec 23: UNITED STATES (53.38%), and Rest Of World (46.62%).
GSK Peer Comparison by Revenue
| Ticker | Company | Last Year Revenue | Last Quarter Revenue |
|---|---|---|---|
| JNJ | Johnson & Johnson | $85.15B | $22.47B |
| MRK | Merck | $60.12B | $16.11B |
| ABBV | AbbVie | $54.32B | $14.46B |
| NVS | Novartis | $46.66B | $11.83B |
| AZN | AstraZeneca | $45.81B | $12.68B |
| BMY | Bristol-Myers Squibb Company | $45.01B | $11.89B |
| SNY | Sanofi | $43.07B | $11.12B |
| GSK | GSK | $30.33B | $7.36B |
| AMGN | Amgen | $28.19B | $8.50B |
| GILD | Gilead Sciences | $27.12B | $6.95B |
| BIIB | Biogen | $9.84B | $2.47B |
GSK Revenue FAQ
What is GSK’s yearly revenue?
GSK's yearly revenue for 2023 was $30.33B, representing an increase of 3.42% compared to 2022. The company's yearly revenue for 2022 was $29.32B, representing a decrease of -14.04% compared to 2021. GSK's yearly revenue for 2021 was $34.11B, representing an increase of 0.04% compared to 2020.
What is GSK’s quarterly revenue?
GSK's quarterly revenue for Q1 2024 was $7.36B, a -8.56% decrease from the previous quarter (Q4 2023), and a 5.93% increase year-over-year (Q1 2023). The company's quarterly revenue for Q4 2023 was $8.05B, a -1.17% decrease from the previous quarter (Q3 2023), and a 9.16% increase year-over-year (Q4 2022). GSK's quarterly revenue for Q3 2023 was $8.15B, a 13.50% increase from the previous quarter (Q2 2023), and a 4.06% increase year-over-year (Q3 2022).
What is GSK’s revenue growth rate?
GSK's revenue growth rate for the last 3 years (2021-2023) was -11.10%, and for the last 5 years (2019-2023) was -10.15%.
What are GSK’s revenue streams?
GSK's revenue streams in c 22 are Sub Total
What is GSK’s main source of revenue?
For the fiscal year ending Dec 22, the largest source of revenue of GSK was Sub Total. This segment made a revenue of $8.96B, representing 100.00% of the company's total revenue.